Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Immuno-Oncology Technology|July 24, 2023
Immuno-oncology approaches in uveal melanoma: tebentafusp and beyondC Gerard, B Shum, P Nathan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 2021
Immunotherapy use outside clinical trial populations: never say never?K Rzeniewicz, J Larkin, A M Menzies, et al.
Immuno-Oncology Technology|March 13, 2023
TCR sequencing: applications in immuno-oncology researchÁ F Sanromán, K Joshi, L Au, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2016
Acute renal allograft rejection after immune checkpoint inhibitor therapy for metastatic melanomaL Spain, R Higgins, K Gopalakrishnan, et al.
Journal of Endocrinological Investigation|May 26, 2020
Predicting development of ipilimumab-induced hypophysitis: utility of T4 and TSH index but not TSHM S Siddiqui, Z M Lai, L Spain, et al.
Clinical and Experimental Dermatology|October 3, 2020
Cutaneous toxicities in patients with melanoma receiving checkpoint inhibitor therapy: a retrospective review. The experience of a single large specialist institutionC L Edwards, F Comito, S Agraso Busto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 21, 2017
Neurotoxicity from immune-checkpoint inhibition in the treatment of melanoma: a single centre experience and review of the literatureL Spain, G Walls, M Julve, et al.
ESMO Open|May 17, 2025
Fatal intracranial haemorrhage shortly after belzutifan initiation in von Hippel-Lindau (VHL) disease-associated haemangioblastomaS T C Shepherd, C Kelly-Morland, S Drage, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2014
Whole-genome sequencing reveals complex mechanisms of intrinsic resistance to BRAF inhibitionS Turajlic, S J Furney, G Stamp, et al.
The British Journal of Radiology|January 25, 2026
Efficacy and safety of Stereotactic Radiosurgery (SRS) in the management of brain metastases in patients with metastatic melanomaD J McMahon, M Aboulela, J De Boisanger, et al.
Pageof 2